Friday, June 30, 2017

ORAL CONTRACEPTIVES AND TOBACCO USE



Women who smoke and use oral contraceptives, particularly after age of 35, are placing themselves at a much greater risk of experiencing a fatal cardiovascular accident (heart attack, stroke, or embolism) than oral contraceptive users who do not smoke.  This risk of cardiovascular complications increases further for oral contraceptive users 40 years of age or older.  Women who both smoke and use oral contraceptives are four times more likely to die from myocardial infarction (heart attack) than women who only smoke.  Because of this adverse relationship, it is strongly recommended that women who smoke should not use oral contraceptives.
Share:

SMOKING AND REPRODUCTION


In all of its dimensions, the reproductive process is impaired by the use of tobacco, particularly cigarette smoking.  Problems can be found in association with infertility, problem pregnancy, breastfeeding, and the health of the newborn.  So broadly based are reproductive problems and smoking that the term fetal tobacco syndrome or fetal smoking syndrome is regularly used in clinical medicine.  Some physicians even define a fetus being carried by a smoker as a “smoker” and, upon birth, as a “former smoker.”
Infertility
Recent research indicates that cigarette smoking by both men and women can reduce levels of fertility.  Among men, smoking adversely affects blood flow to erectile tissue, reduces sperm motility, and alters sperm shape, and it causes an overall decrease in the number of viable sperm.  Among women, the effects of smoking are seen in terms of abnormal ovum formation, including a lessened ability on the part of the egg to prevent polyspermia, or the fertilization by multiple sperm.  Smoking also negatively influences estrogen levels, resulting in underdevelopment of the uterine wall and ineffective implantation of the fertilized ovum.  Lower levels of estrogen may also influence the rate of transit of the fertilized egg through the fallopian tube, making it arrive in the uterus too early for successful implantation or, in some cases, restricting movement to the point that an ectopic, or tubal, pregnancy may develop.  Also, the early onset of menopause is associated with smoking.
Problem pregnancy
The harmful effects of tobacco smoke on the course of pregnancy are principally the result of the carbon monoxide and nicotine to which the mother and her fetus are exposed.  Carbon monoxide from the incomplete oxidation of tobacco is carried in the maternal blood to the placenta, where it diffuses across the placental barrier and enters the fetal circulation.  Once in the fetal blood, the carbon monoxide bonds with the fetal hemoglobin to form fetal carboxyhemoglobin.  As a result of this exposure to carbon monoxide, the fetus is progressively deprived of normal oxygen transport and eventually becomes compromised by chronic hypoxia.
Nicotine also exerts its influence on the developing fetus.  Thermographs of the placenta and fetus show signs of marked vasoconstriction within a few seconds after inhalation by the mother.  This constriction further reduces the oxygen supply, resulting in hypoxia.  In addition, nicotine stimulates the mother’s stress response, placing the mother and fetus under the potentially harmful influence of elevated epinephrine and corticoid levels.  Any fetus exposed to all of these agents is more likely to be miscarried, stillborn, or born prematurely.  Even when carried to term, children born to mothers who smoked during pregnancy have lower birth weights and may show other signs of a stressful intrauterine life.
Breastfeeding
For women who decide to breastfeed their infants, smoking during this period will continue to expose their children to the harmful effects of tobacco smoke.  It is well recognized that nicotine appears in breast milk and thus is capable of exerting its vasoconstricting and stress-response influences on nursing infants.  Mothers who stop smoking during pregnancy should be encouraged to continue to refrain from smoking while they are breastfeeding.
Neonatal Health Problems
Babies born to women who smoked during pregnancy will, on average, be shorter and have a lower birth weight than children born to nonsmoking mothers.  During the earliest months of life, babies born to mothers who smoke experience an elevated rate of death caused by sudden infant death syndrome.  Statistics also show that infants are more likely to develop chronic respiratory problems, be hospitalized, and have poorer overall health during their early years of life.  Problems such as those just mentioned may also be seen in children of nonsmoking mothers, when they were exposed prenatally to environmental tobacco smoke.  In addition, environmental tobacco smoke exposure extending beyond the home and into the workplace may increase the probability of problem pregnancies and neonatal health problems.  Most recently, the interest in the effects of tobacco smoke on pregnancy has been extended to include behavioral differences seen in infants born to women who smoked during pregnancy.
Parenting, in the sense of assuming responsibility for the well-being of children, does not begin at birth, but during the prenatal period.  In the case of smoking, this is especially true.  Pregnant women who continue smoking are disregarding the well-being of the children they are carrying.  Other family members, friends, and coworkers who subject pregnant women to cigarette, pipe, or cigar smoke are, in a sense, exhibiting their own disregard for the health of the next generation.
Share:

Wednesday, June 21, 2017

ILLNESS, PREMATURE DEATH, AND TOBACCO USE


For people who begin tobacco use as adolescents or young adults, smoke heavily, and continue to smoke, the likelihood of premature death is virtually ensured.  Two-pack-a-day cigarette smokers can expect to die 7 to 8 years earlier than their nonsmoking counterparts.  (only nonsmoking-related deaths than can afflict smokers and nonsmokers alike keep the difference at this level rather than much higher.)  not only will these people die sooner, but they will also probably be plagued with painful, debilitating illnesses for an extended time.  Smoking is responsible for nearly 440,000 premature deaths each year.
Cardiovascular Disease
Cardiovascular disease is the leading cause of death among all adults, accounting for 945,836 deaths in the United States in 2000.  Tobacco use, and cigarette smoking in particular, is clearly one of the major factors contributing to this cause of death.  Although overall progress is being made in reducing the incidence of cardiovascular-related deaths, tobacco use impedes these efforts.  So important is tobacco use as a contributing factor in deaths from cardiovascular disease that the cigarette smoker more than doubles the risk of experiencing a myocardial infarction, the leading cause of death from cardiovascular disease.  Smokers also increase their risk of sudden cardiac death by two to four times.  Fully one-third of all cardiovascular disease can be traced to cigarette smoking.
The relationship between tobacco use and cardiovascular disease is centered on two major components of tobacco smoke: nicotine and carbon monoxide.
Nicotine and Cardiovascular Disease
The influence of nicotine on the cardiovascular system occurs when it stimulates the nervous system to release nor-epinephrine.  This powerful stimulant increases the heart rate.  In turn, an elevated heart rate increases cardiac output, thus increasing blood pressure.  The extent to which this is dangerous depends in part on the coronary circulation’s ability to supply blood to the rapidly contracting heart muscle.  The development of angina pectoris and the possibility of sudden heart attack are heightened by this sustained elevation of heart attack are heightened by individuals with existing coronary artery disease.
Nicotine is also a powerful vasoconstrictor of the peripheral blood vessels.  As these vessels are constricted by the influence of nicotine, the pressure against their wall increases.  Recent research shows that irreversible atherosclerotic damage to major arteries also occurs with smoking.
Nicotine also increases blood platelet adhesiveness.  As the platelets become more and more likely to “clump,” a person will be more likely to develop a blood clot.  In people already prone to cardiovascular disease, more rapidly clotting blood is an unwelcome liability.  Heart attacks occur when clots form within the coronary arteries or are transported to the heart from other areas of the body.
In addition to other influences on the cardiovascular system, nicotine possesses the ability to decrease the proportion of high-density lipoproteins (HDLs) and to increase the proportion of low-density lipoproteins (LDLs) and very-low-density lipoproteins that constitute the body’s serum cholesterol.  Low-density lipoproteins appear to support the development of atherosclerosis and are clearly increased in the bloodstream of smokers.
Carbon Monoxide and Cardiovascular Disease
A second substance contributed to tobacco influences the type and extent of cardiovascular disease found among tobacco users.  Carbon monoxide interferes with oxygen transport within the circulatory system.
Carbon monoxide is a component of the gaseous phase of tobacco smoke and readily joins with the hemoglobin of the red blood cells.  Carbon monoxide has an affinity for hemoglobin 206 times that of oxygen.  Once the hemoglobin of a red cell has accepted carbon monoxide molecules, the hemoglobin is transformed into carboxyhemoglobin.  Thereafter, the carboxyhemoglobin permanently weakens the red blood cell’s ability to transport oxygen.  So long as smoking continues, these red blood cells remain relatively useless during the remainder of their 120-day lives.  Levels of carboxyhemoglobin in heavy smokers are associated with significant increases in the incidence of myocardial infarction.
When a person has impaired oxygen-transporting abilities, physical exertion becomes increasingly demanding on both the heart and lungs.  The cardiovascular system will attempt to respond to the body’s demand for oxygen, but these responses are themselves impaired as a result of the influence of nicotine on the cardiovascular system.  If tobacco does create the good life, as advertisers claim, it also unfortunately lessens the ability to participate actively in that life.
Cancer
Over the past 60 years, research from the most reputable institutions in this country and abroad has consistently concluded that tobacco use is significant factor in the development of virtually all forms of cancer and the most significant factor in cancers involving the respiratory system.
In describing cancer development, the currently used reference is 20 pack-years, or an amount of smoking equal to smoking one pack of cigarettes a day for 20 years.  Thus the two-pack-a-day can anticipate cancer-related tissue changes in as few as 10 years, while the half-pack-a-day smoker may have 40 years to wait.  Regardless, the opportunity is there for all smokers to confirm these data by developing cancer as predicted.  It is hoped that most people will think twice before disregarding this evidence.
Data supplied by the American Cancer Society (ACS) indicate that during 2003 an estimated 1,334,000 Americans developed cancer.  These cases were nearly equally divided between the sexes and resulted in approximately 556,500 deaths.  In the opinion of the ACS, 30% of all cancer cases are heavily influenced by tobacco use.  Lung cancer along accounted for about 171,900 of the new cancer cases and 157,200 deaths in 2003.  Fully 87% of men with lung cancer were cigarette smokers.  A genetic “missing link” between smoking and lung cancer was established, when mutations to an important tumor suppressor gene were identified.  If it was necessary to have a final “proof” that smoking causes lung cancer, that proof appears to be in hand.
Cancer of the entire respiratory system, including lung cancer and cancers of the mouth and throat, accounted for about 185,200 new cases of cancer and 163,700 deaths.  Despite these high figures, not all smokers develop cancer.
Respiratory Tract Cancer
Recall that tobacco smoke produces both a gaseous and a particulate phase.  As noted, the particulate phase contains the tar fragment of tobacco smoke.  This rich chemical environment contains more than four thousand known chemical compounds, hundreds of which are known to be carcinogens.
In the normally functioning respiratory system, particulate matter suspended in the inhaled air settles on the tissues lining the airways and is trapped in mucus produced by specialized goblet cells.  This mucus, with its trapped impurities, is continuously swept upward by the beating action of hairlike cilia of the ciliated columnar epithelial cells lining the air passages.  On reaching the throat, this mucus is swallowed and eventually removed through the digestive system.
When tobacco smoke is drawn into the respiratory system, however, its rapidly dropping temperature allows the particulate matter to accumulate.  This brown, sticky tar contains compounds known to harm the ciliated cells, goblet cells, and the basal cells of the respiratory lining.  As the damage from smoking increases, the cilia become less effective in sweeping mucus upward to the throat.  When cilia can no longer clean the airway, tar accumulates on the surfaces and brings carcinogenic compounds into direct contact with the tissues of the airway.
At the same time that the sweeping action of the lining cells is being slowed, substances in the tar are stimulating the goblet cells to increase the amount of mucus they normally produce.  The “smoker’s cough” is the body’s attempt to remove this excess mucus.
With prolonged exposure to the carcinogenic materials in tar, predicable changes will begin to occur within the respiratory system’s basal cell layer.  The basal cell begin to display changes characteristic of all cancer cells.  In addition, an abnormal accumulation of cells occurs.  When a person stops smoking, preinvasive lesions do not repair themselves as quickly as once thought.
By the time lung cancer is usually diagnosed, its development is so advanced that the chance for recovery is very poor. Still today, only 15% of all lung cancer victims survive for 5 years or more after diagnosis.  Most die in a very uncomfortable, painful way.
Cancerous activity in other areas of the respiratory system, including the larynx, and within the oral cavity (mouth) follows a similar course.  In the case of oral cavity cancer, carcinogens found within the smoke and within the saliva are involved in the cancerous changes.  Tobacco users, such as pipe smokers, cigar smokers, and users of smokeless tobacco, have a higher (4 to 10 times) rate of cancer of the mouth, tongue, and voice box.
In addition to drawing smoke into the lungs, tobacco users swallows saliva that contains an array of chemical compounds from tobacco.  As this saliva is swallowed, carcinogens are absorbed into the circulatory system and transported to all areas of the body.  The filtering of the blood by the liver, kidneys, and bladder may account for the higher-than-normal levels of cancer in these organs among smokers.
Documents released in 1997 from within the tobacco industry clearly show that the major tobacco companies were aware of tobacco’s role in the development of cancer and had made a concerted effort to deprive the American public access to such knowledge.
Chronic Obstructive Lung Disease
Chronic obstructive lung disease (COLD), also known as chronic obstructive pulmonary disease (COPD), is a disorder in which the amount of air that flows in and out of the lungs becomes progressively limited.  COLD is a disease state that is made up of two separate but related diseases: chronic bronchitis and pulmonary emphysema.
With chronic bronchitis, excess mucus is produce in response to the effects of smoking on airway tissue, and the walls of the bronchi become inflamed and infected.  This produces a characteristic narrowing of the air passages.  Breathing becomes difficult, and activity can be severely restricted.  With cessation of smoking, chronic bronchitis is reversible.
Emphysema causes irreversible damage to the tiny air sacs of the lungs, the alveoli.  Chest pressure builds when air becomes trapped by narrowed air passages (chronic bronchitis) and the thin-walled sacs rupture.  Emphysema patients lose the ability to ventilate fully.  They feel as though they are suffocating.  You may have seen people with this condition in malls and other locations as they walk slowly by, carrying or pulling their portable oxygen tanks.
More than 10 million Americans suffer from COLD.  It is responsible for a greater limitation of physical activity than any other disease, including heart disease.  COLD patients tend to die a very unpleasant, prolonged death, often from a general collapse of normal cardiorespiratory function that result in congestive heart failure.
Additional Health Concerns
In addition to the serious health problems stemming from tobacco use already described, other health related changes are routinely seen.  These include a generally poor state of nutrition, the gradual loss of the sense of smell, and premature wrinkling of the skin.  Tobacco users are also more likely to experience strokes (a potentially fatal condition), lose body mass leading to osteoporosis, experience more back pain and muscle injury, and find that fractures heal more slowly.  Further, smokers who have surgery spend more time in the recovery room.  Although not perceived as a health problem by people who continue smoking in order to control weight, smoking does appear to minimize weight gain.  In studies using identical twins, twins who smoked were six to eight pounds lighter than their nonsmoking siblings.  Current understanding about why smoking results in lower body weight is less than complete.  One factor may be an increase in Basal Metabolic Rate (BMR) brought about by the influence of nicotine on sympathetic nervous system function.  Additionally, smokers have a fourfold greater risk of developing serious gum (periodontal) disease.  Also, smokers may need supplementation for two important water-soluble vitamins, vitamin C and vitamin B.
Share: